Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial
Title:
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial
Author:
Long, Georgina V Luke, Jason J Khattak, Muhammad A de la Cruz Merino, Luis Del Vecchio, Michele Rutkowski, Piotr Spagnolo, Francesco Mackiewicz, Jacek Chiarion-Sileni, Vanna Kirkwood, John M Robert, Caroline Grob, Jean-Jacques de Galitiis, Federica Schadendorf, Dirk Carlino, Matteo S Mohr, Peter Dummer, Reinhard Gershenwald, Jeffrey E Yoon, Charles H Wu, Xi Lawrence Fukunaga-Kalabis, Mizuho Krepler, Clemens Eggermont, Alexander M M Ascierto, Paolo A